Klaria Pharma
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar! Correction: Incorrect inclusion of MAR text in earlier release.Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ)
REG
- In light of the Company's collaboration with BDO LLP's UK Life Sciences M&A team regarding business development efforts in strategically important markets, the extraordinary general meeting unanimously resolved that the current auditor, BDO Mälardalen AB, shall resign from its engagement and that Azets Revision & Rådgivning AB, reg. no. 559480-5169, shall instead be appointed as auditor, with Per Hammar as the auditor in charge.
- It was resolved unanimously that the merger plans regarding the absorption of the wholly owned subsidiaries Klaria Incentive AB, company reg.no. 559084-7793, Karessa Incentive AB, company reg.no. 559114-8514 och Karessa Pharma AB, company reg.no. 556966-7420, established on May 24, 2025, shall be applicable in Klaria Pharma Holding AB (publ).
Stockholm, March 19, 2026
KLARIA PHARMA HOLDING AB (publ)
The board of directors